Zydus Lifesciences’ Menostar Transdermal System generic gets FDA final approval
Zydus Lifesciences has secured final approval from the UA Food and Drug Administration (FDA) for Estradiol Transdermal System USP, 0.014 mg/day. The approved product which ... Read More
Zydus Lifesciences gets FDA approval for Estradiol Transdermal System
Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day ... Read More